drugset
drugset / Trial / NCT02036229

Topical 0.5% Ivermectin Cream for Treatment of Demodicidosis

NCT02036229 ↗

Phase 3 Unknown 50 enrolled Rabin Medical Center
RandomizedParallel-groupTriple-blindTreatment

Summary

The purpose of this study is to determine whether 0.5% ivermectin cream is effective in the treatment of demodicidosis (including papulopustular rosacea)

Timeline

Start
2014-02
Primary completion
2015-12
Completion
2016-06

Drugs

EvaluationDrugModalityDoseRoute
Subject Ivermectin Small molecule 0.5 % Topical

Indications

demodicidosis rosacea